{"id":1014602,"date":"2026-10-28T09:59:31","date_gmt":"2026-10-28T13:59:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/"},"modified":"2026-10-28T09:59:31","modified_gmt":"2026-10-28T13:59:31","slug":"astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/","title":{"rendered":"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing"},"content":{"rendered":"

<\/p>\n

AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark<\/i> to Raise Awareness of Cancer Biomarker Testing<\/b><\/p>\n

Campaign encourages people to take a \u201ctime out\u201d to learn more about cancer biomarker testing, which can guide more personalized cancer treatment decisions<\/i><\/b><\/p>\n

WILMINGTON, Del.–(BUSINESS WIRE<\/a>)–
\nAstraZeneca today announced the launch of Meet Your Mark<\/i><\/a>, a new public health campaign featuring actor Mark-Paul Gosselaar. The campaign encourages people to ask about biomarker testing if they or a loved one is diagnosed with cancer, helping make biomarker testing a standard part of the cancer care conversation.<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20261028294394\/en\/<\/a><\/p>\n

\"AstraZeneca<\/p>\n

AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing<\/p>\n<\/div>\n

\nLeaning into nostalgia for audiences who watched him early in his career, Mark-Paul acts as a warm, relatable guide showing how biomarker testing may give important information about a person\u2019s unique cancer and support healthcare providers in making more informed and personalized treatment decisions.<\/p>\n

\nMark-Paul said: \u201cHaving seen loved ones navigate cancer diagnoses, I felt it was important to spread the word about biomarker testing. It\u2019s a process that may help people better understand their cancer and help healthcare providers match them with a treatment that may target their specific biomarker. By bringing back my history of calling a \u2018time out\u2019, we\u2019re empowering those living with cancer to take a moment to ask their doctor about biomarker testing, enabling them to play a more active role in their care.\u201d<\/p>\n

\nBiomarkers are health clues or signs in the body\u2014like genes, proteins, or other substances\u2014that doctors can measure through blood or tissue tests. Biomarker testing may tell a doctor about the specific type of cancer present, how aggressive it might be, whether a treatment is working, or if targeted therapies or immunotherapies might help. Even if two people have the same type of cancer, their tumors can behave differently. Biomarkers can decode these differences, helping people and their doctors choose the next step in their treatment plan.<\/p>\n

\nMedical groups recommend biomarker testing for many cancers, including lung, breast, ovarian, prostate, colorectal, melanoma, and certain blood cancers.1<\/sup> In a study of more than 1,200 people impacted by cancer, more than 75% of those who had biomarker testing said it gave their doctor valuable information to help guide their treatment plan.2<\/sup><\/p>\n

\nHowever, biomarker testing rates in the US remain low: only about one-third of people with advanced cancer receive testing, despite established medical guidelines.3,4<\/sup><\/p>\n

\nMohit Manrao, Senior Vice President, Head of US Oncology, AstraZeneca, said: \u201cAt AstraZeneca, our goal is to one day eliminate cancer as a cause of death. We believe biomarker testing has a critical role to play in making this possible by providing doctors with valuable insights to guide cancer care. Through Meet Your Mark<\/i> and our partnership with Mark-Paul Gosselaar, we\u2019re calling attention to biomarkers as a powerful tool in navigating a cancer diagnosis, supporting our broader commitment to cancer care.\u201d<\/p>\n

Meet Your Mark <\/i>features real stories from people living with cancer, as well as healthcare provider perspectives sharing how biomarker testing may help change the course of a person\u2019s treatment journey.<\/p>\n

\nVisit MeetYourMark.com<\/a> to learn more about biomarkers and find resources from cancer advocacy groups.<\/p>\n

\nFollow AstraZeneca on LinkedIn<\/a>, Instagram<\/a>, Facebook<\/a>, and YouTube<\/a> for Meet Your Mark<\/i> campaign content.<\/p>\n

Notes<\/span><\/b><\/p>\n

AstraZeneca in Oncology
\n
<\/b>AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients.<\/p>\n

\nThe Company focuses on some of the most challenging cancers. It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyze changes in the practice of medicine and transform the patient experience.<\/p>\n

\nAstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.<\/p>\n

AstraZeneca
\n
<\/b>AstraZeneca (LSE\/STO\/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca\u2019s innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca-us.com<\/a> and follow the Company on social media @AstraZeneca<\/a>.<\/p>\n

References:<\/b><\/p>\n

    \n
  1. \nNational Comprehensive Cancer Network. Policy priority: Guidelines and compendia as health policy tool. Accessed June 4, 2026. https:\/\/www.nccn.org\/business-policy\/policy-and-advocacy-program\/policy-priorities\/policy-priority-guidelines-as-a-health-policy-tool<\/a>.<\/p>\n<\/li>\n
  2. \nAmerican Cancer Society. Cancer patients and survivors overwhelmingly agree biomarker testing improved their treatment. Accessed June 4, 2026. https:\/\/www.fightcancer.org\/policy-resources\/cancer-patients-and-survivors-overwhelmingly-agree-biomarker-testing-improved-their<\/a>.<\/p>\n<\/li>\n
  3. \nOncology Nursing Society. ONS Voice: Only a third of patients with advanced cancer get biomarker testing, limiting use of potentially effective precision therapies. Accessed June 4, 2026. https:\/\/www.ons.org\/publications-research\/voice\/news-views\/09-2025\/only-third-patients-advanced-cancer-get-biomarker<\/a>.<\/p>\n<\/li>\n
  4. \nDaCosta Byfield S, Bapat B, Becker L, et al. Biomarker testing approaches, treatment selection, and cost of care among adults with advanced cancer. JAMA Netw Open<\/i>. 2025;8(7):e2519963. doi:10.1001\/jamanetworkopen.2025.19963<\/p>\n<\/li>\n<\/ol>\n

    \nUS-116838 Last Updated 10\/26<\/p>\n

    \"\"<\/p>\n

    View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20261028294394\/en\/<\/a><\/span><\/p>\n

    Media Inquiries
    \n<\/b>
    Lauren-Jei McCarthy +1 347 918 7001<\/p>\n

    \nUS Media Mailbox: usmediateam@astrazeneca.com<\/a><\/p>\n

    KEYWORDS:<\/b> Delaware United States North America<\/p>\n

    INDUSTRY KEYWORDS:<\/b> Oncology Health Research Pharmaceutical Science Biotechnology<\/p>\n

    MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
    Photo<\/b><\/font><\/td>\n<\/tr>\n
    \"Photo\"<\/td>\n<\/tr>\n
    AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing<\/font><\/td>\n<\/tr>\n
    Photo<\/b><\/font><\/td>\n<\/tr>\n
    \"Photo\"<\/td>\n<\/tr>\n
    AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing<\/font><\/td>\n<\/tr>\n
    Photo<\/b><\/font><\/td>\n<\/tr>\n
    \"Photo\"<\/td>\n<\/tr>\n
    AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing<\/font><\/td>\n<\/tr>\n
    Logo<\/b><\/font><\/td>\n<\/tr>\n
    \"Logo\"<\/td>\n<\/tr>\n
    <\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

    AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing Campaign encourages people to take a \u201ctime out\u201d to learn more about cancer biomarker testing, which can guide more personalized cancer treatment decisions WILMINGTON, Del.–(BUSINESS WIRE)– AstraZeneca today announced the launch of Meet Your Mark, a new public health campaign featuring actor Mark-Paul Gosselaar. The campaign encourages people to ask about biomarker testing if they or a loved one is diagnosed with cancer, helping make biomarker testing a standard part of the cancer care conversation. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20261028294394\/en\/ AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing Leaning into nostalgia for … <\/p>\n

    Continue reading “AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1014602","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing Campaign encourages people to take a \u201ctime out\u201d to learn more about cancer biomarker testing, which can guide more personalized cancer treatment decisions WILMINGTON, Del.–(BUSINESS WIRE)– AstraZeneca today announced the launch of Meet Your Mark, a new public health campaign featuring actor Mark-Paul Gosselaar. The campaign encourages people to ask about biomarker testing if they or a loved one is diagnosed with cancer, helping make biomarker testing a standard part of the cancer care conversation. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20261028294394\/en\/ AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing Leaning into nostalgia for … Continue reading "AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-28T13:59:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20261028294394\/en\/2947887\/4\/DSC02787_FINAL_V2.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing\",\"datePublished\":\"2026-10-28T13:59:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/\"},\"wordCount\":951,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261028294394\\\/en\\\/2947887\\\/4\\\/DSC02787_FINAL_V2.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/\",\"name\":\"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261028294394\\\/en\\\/2947887\\\/4\\\/DSC02787_FINAL_V2.jpg\",\"datePublished\":\"2026-10-28T13:59:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261028294394\\\/en\\\/2947887\\\/4\\\/DSC02787_FINAL_V2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261028294394\\\/en\\\/2947887\\\/4\\\/DSC02787_FINAL_V2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing - Market Newsdesk","og_description":"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing Campaign encourages people to take a \u201ctime out\u201d to learn more about cancer biomarker testing, which can guide more personalized cancer treatment decisions WILMINGTON, Del.–(BUSINESS WIRE)– AstraZeneca today announced the launch of Meet Your Mark, a new public health campaign featuring actor Mark-Paul Gosselaar. The campaign encourages people to ask about biomarker testing if they or a loved one is diagnosed with cancer, helping make biomarker testing a standard part of the cancer care conversation. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20261028294394\/en\/ AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing Leaning into nostalgia for … Continue reading \"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-28T13:59:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20261028294394\/en\/2947887\/4\/DSC02787_FINAL_V2.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing","datePublished":"2026-10-28T13:59:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/"},"wordCount":951,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20261028294394\/en\/2947887\/4\/DSC02787_FINAL_V2.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/","name":"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20261028294394\/en\/2947887\/4\/DSC02787_FINAL_V2.jpg","datePublished":"2026-10-28T13:59:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20261028294394\/en\/2947887\/4\/DSC02787_FINAL_V2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20261028294394\/en\/2947887\/4\/DSC02787_FINAL_V2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/astrazeneca-and-mark-paul-gosselaar-launch-meet-your-mark-to-raise-awareness-of-cancer-biomarker-testing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1014602"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014602\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1014602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1014602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1014602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}